Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart

British Journal of Pharmacology

Volumn 172, Issue 8, 2015, Pages 2026-2050

  Headrick, John P ^a   See Hoe, Louise E ^a   Du Toit, Eugene F ^a   Peart, Jason N ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; ACETYLSALICYLIC ACID; DELTA OPIATE RECEPTOR; DELTORPHIN D; DELTORPHIN E; DELTORPHIN II; DIAZEPAM; DYNORPHIN B; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ERIBIS PEPTIDE 94; FENTANYL; FENTANYL ISOTHIOCYANATE; G PROTEIN COUPLED RECEPTOR; GLIBENCLAMIDE; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; OPIATE; OPIATE AGONIST; OPIATE RECEPTOR; REMIFENTANIL; SNC 121; SPIRADOLINE; SUFENTANIL; SULFONYLUREA; UNCLASSIFIED DRUG; UNINDEXED DRUG; CARDIOTONIC AGENT; NARCOTIC ANALGESIC AGENT;

ACUTE HEART INFARCTION; AGING; CLINICAL TRIAL (TOPIC); COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG TARGETING; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTROPHY; ISCHEMIC HEART DISEASE; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LOW DRUG DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SARCOLEMMA; STRESS; AGONISTS; ANIMAL; CARDIAC MUSCLE; HEART INFARCTION PREVENTION; METABOLISM; MYOCARDIAL INFARCTION; PHYSIOLOGICAL STRESS;

AGING; ANALGESICS, OPIOID; ANIMALS; CARDIOTONIC AGENTS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIUM; RECEPTORS, OPIOID; STRESS, PHYSIOLOGICAL;

EID: 84925844462     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13042     Document Type: Review

References (213)

1. Abdel-Wahab M, Khattab AA, Liska B, Kassner G, Geist V, Toelg R, et al. (2008). Diazepam versus fentanyl for premedication during percutaneous coronary intervention: results from the Myocardial Protection by Fentanyl during Coronary Intervention (PROFIT) Trial. J Interv Cardiol 21: 232-238.
2. Abete P, Ferrara N, Cacciatore F, Madrid A, Bianco S, Calabrese C, et al. (1997). Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol 30: 947-954.
3. Addison PD, Neligan PC, Ashrafpour H, Khan A, Zhong A, Moses M, et al. (2003). Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol 285: H1435-H1443.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors. Br J Pharmacol 170: 1459-1581.
5. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors. Br J Pharmacol 170: 1676-1705.
6. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, et al. (2013c). The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels. Br J Pharmacol 170: 1607-1651.
7. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013d). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
8. Al-Hasani R, Bruchas MR, (2011). Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115: 1363-1381.
9. Ashton KJ, Tupicoff A, Williams-Pritchard G, Kiessling CJ, See Hoe LE, Headrick JP, et al. (2013). Unique transcriptional profile of sustained ligand-activated preconditioning in pre- and post-ischemic myocardium. PLoS ONE 8: e72278.
10. Barron BA, (2000). Cardiac opioids. Proc Soc Exp Biol Med 224: 1-7.
11. Bell SP, Sack MN, Patel A, Opie LH, Yellon DM, (2000). Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 36: 2296-2302.
12. Bolling SF, Benedict MB, Tramontini NL, Kilgore KS, Harlow HH, Su TP, et al. (1998). Hibernation triggers and myocardial protection. Circulation 98: II-220-II-224.
13. Boluyt MO, Younes A, Caffrey JL, O'Neill L, Barron BA, Crow MT, et al. (1993). Age-associated increase in rat cardiac opioid production. Am J Physiol 265: H212-H218.
14. Bouhidel O, Pons S, Souktani R, Zini R, Berdeaux A, Ghaleh B, (2008). Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol Heart Circ Physiol 295: H1580-H1586.
15. van den Brink OW, Delbridge LM, Pedrazzini T, Rosenfeldt FL, Pepe S, (2007). Augmented myocardial methionine-enkephalin in a murine model of cardiac angiotensin II-overexpression. J Renin Angiotensin Aldosterone Syst 8: 153-159.
16. Bruce DS, Bailey EC, Setran DP, Tramell MS, Jacobson D, Oeltgen PR, et al. (1996). Circannual variations in bear plasma albumin and its opioid-like effects on guinea pig ileum. Pharmacol Biochem Behav 53: 885-889.
17. Caffrey JL, Boluyt MO, Younes A, Barron BA, O'Neill L, Crow MT, et al. (1994). Aging, cardiac proenkephalin mRNA and enkephalin peptides in the Fisher 344 rat. J Mol Cell Cardiol 26: 701-711.
18. 2+ channel blockade prevents ischemic preconditioning of human myocardium. J Mol Cell Cardiol 31: 2191-2197.
19. Cao CM, Xia Q, Tu J, Chen M, Wu S, Wong TM, (2004). Cardioprotection of interleukin-2 is mediated via kappa-opioid receptors. J Pharmacol Exp Ther 309: 560-567.
20. Cao CM, Chen M, Wong TM, (2005). The K(Ca) channel as a trigger for the cardioprotection induced by kappa-opioid receptor stimulation-its relationship with protein kinase C. Br J Pharmacol 145: 984-991.
21. Cao Z, Liu L, Van Winkle DM, (2003). Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels. Am J Physiol Heart Circ Physiol 285: H1032-H1039.
22. Chang MC, Lee AY, Lin WY, Chen TJ, Shyu MY, Chang WF, (2004). Myocardial and peripheral concentrations of beta-endorphin before and following myocardial ischemia and reperfusion during coronary angioplasty. Jpn Heart J 45: 365-371.
23. Chaudhary KR, Cho WJ, Yang F, Samokhvalov V, El-Sikhry HE, Daniel EE, et al. (2013). Effect of ischemia reperfusion injury and epoxyeicosatrienoic acids on caveolin expression in mouse myocardium. J Cardiovasc Pharmacol 61: 258-263.
24. Chen QL, Gu EW, Zhang L, Cao YY, Zhu Y, Fang WP, (2013). Diabetes mellitus abrogates the cardioprotection of sufentanil against ischaemia/reperfusion injury by altering glycogen synthase kinase-3β. Acta Anaesthesiol Scand 57: 236-242.
25. Chen Z, Li T, Zhang B, (2008). Morphine post-conditioning protects against reperfusion injury in the isolated rat hearts. J Surg Res 145: 287-294.
26. Cheng L, Ma S, Wei LX, Guo HT, Huang LY, Bi H, et al. (2007). Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart. Heart Vessels 22: 335-344.
27. Chien S, Oeltgen PR, Diana JN, Salley RK, Su TP, (1994). Extension of tissue survival time in multiorgan block preparation using a delta opioid DADLE. J Thorac Cardiovasc Surg 107: 964-967.
28. Cohen MV, Philipp S, Krieg T, Cui L, Kuno A, Solodushko V, et al. (2007). Preconditioning-mimetics bradykinin and DADLE activate PI3-kinase through divergent pathways. J Mol Cell Cardiol 42: 842-851.
29. Dickson EW, Blehar DJ, Carraway RE, Heard SO, Steinberg G, Przyklenk K, (2001). Naloxone blocks transferred preconditioning in isolated rabbit hearts. J Mol Cell Cardiol 33: 1751-1756.
30. Dickson EW, Hogrefe CP, Ludwig PS, Ackermann LW, Stoll LL, Denning GM, (2008). Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism. Am J Physiol Heart Circ Physiol 294: H402-H408.
31. Donner D, Headrick JP, Peart JN, du Toit EF, (2013). Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats. Dis Model Mech 6: 457-466.
32. Drastichova Z, Skrabalova J, Jedelsky P, Neckar J, Kolar F, Novotny J, (2012). Global changes in the rat heart proteome induced by prolonged morphine treatment and withdrawal. PLoS ONE 7: e47167.
33. Dumont M, Ouellette M, Brakier-Gingras L, Lemaire S, (1991). Circadian regulation of the biosynthesis of cardiac Met-enkephalin and precursors in normotensive and spontaneously hypertensive rats. Life Sci 48: 1895-1902.
34. Ebrahim Z, Yellon DM, Baxter GF, (2007). Ischemic preconditioning is lost in aging hypertensive rat heart: independent effects of aging and longstanding hypertension. Exp Gerontol 42: 807-814.
35. Fan Y, Yang S, Zhang X, Cao Y, Huang Y, (2012). Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats. Clin Exp Pharmacol Physiol 39: 938-943.
36. Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R, (2014). Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, post-conditioning, and remote conditioning. Pharmacol Rev 66: 1142-1174.
37. Förster K, Kuno A, Solenkova N, Felix SB, Krieg T, (2007). The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation. Am J Physiol Heart Circ Physiol 293: H1604-H1608.
38. ATP channels. Circ Res 84: 846-851.
39. Fryer RM, Wang Y, Hsu AK, Gross GJ, (2001). Essential activation of PKCδ in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 280: H1346-H1353.
40. Fuardo M, Lemoine S, Lo Coco C, Hanouz JL, Massetti M, (2013). [D-Ala2,D-Leu5]-enkephalin (DADLE) and morphine-induced postconditioning by inhibition of mitochondrial permeability transition pore, in human myocardium. Exp Biol Med (Maywood) 238: 426-432.
41. Galdino GS, Duarte ID, Perez AC, (2010). Participation of endogenous opioids in the antinociception induced by resistance exercise in rats. Braz J Med Biol Res 43: 906-909.
42. Ghosh S, Standen NB, Galiñianes M, (2001). Failure to precondition pathological human myocardium. J Am Coll Cardiol 37: 711-718.
43. Gross ER, Hsu AK, Gross GJ, (2004a). Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res 94: 960-966.
44. Gross ER, Hsu AK, Gross GJ, (2004b). Acute aspirin treatment abolishes, whereas acute ibuprofen treatment enhances morphine-induced cardioprotection. J Pharmacol Exp Ther 310: 185-191.
45. Gross ER, Peart JN, Hsu AK, Auchampach JA, Gross GJ, (2005). Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway. Am J Physiol Heart Circ Physiol 288: H2744-H2749.
46. Gross ER, Hsu AK, Gross GJ, (2006). The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. Am J Physiol Heart Circ Physiol 291: H827-H834.
47. ATP channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res Cardiol 102: 341-349.
48. Gross ER, Hsu AK, Gross GJ, (2007b). Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3β. Diabetes 56: 127-136.
49. ATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol 285: H921-H930.
50. Gross GJ, Baker JE, Hsu A, Wu HE, Falck JR, Nithipatikom K, (2010). Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts. Am J Physiol Heart Circ Physiol 298: H2201-H2207.
51. Gross GJ, Hsu A, Nithipatikom K, Bobrova I, Bissessar E, (2012a). Eribis peptide 94 reduces infarct size in rat hearts via activation of centrally located μ opioid receptors. J Cardiovasc Pharmacol 59: 194-197.
52. Gross GJ, Hsu A, Nithipatikom K, Pfeiffer AW, Bobrova I, Bissessar E, (2012b). Acute and chronic cardioprotection by the enkephalin analogue, Eribis peptide 94, is mediated via activation of nitric oxide synthase and adenosine triphosphate-regulated potassium channels. Pharmacology 90: 110-116.
53. Gross RA, Moises HC, Uhler MD, Macdonald RL, (1990). Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents. Proc Natl Acad Sci U S A 87: 7025-7029.
54. Guo HT, Zhang RH, Zhang Y, Zhang LJ, Li J, Shi QX, et al. (2011). Endogenous κ-opioid peptide mediates the cardioprotection induced by ischemic postconditioning. J Cardiovasc Pharmacol 58: 207-215.
55. Habibey R, Pazoki-Toroudi H, (2008). Morphine dependence protects rat kidney against ischaemia-reperfusion injury. Clin Exp Pharmacol Physiol 35: 1209-1214.
56. Hassouna A, Loubani M, Matata BM, Fowler A, Standen NB, Galinanes M, (2006). Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res 69: 450-458.
57. Hausenloy DJ, Lecour S, Yellon DM, (2011). Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 14: 893-907.
58. Head BP, Patel HH, Roth DM, Lai NC, Niesman IR, Farquhar MG, et al. (2005). G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem 280: 31036-31044.
59. Head BP, Patel HH, Insel PA, (2014). Interaction of membrane/lipid rafts with the cytoskeleton: impact on signaling and function: membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling. Biochim Biophys Acta 1838: 532-545.
60. Headrick JP, (1998). Aging impairs functional, metabolic and ionic recovery from ischemia reperfusion and hypoxia-reoxygenation. J Mol Cell Cardiol 30: 1415-1430.
61. Headrick JP, Pepe S, Peart JN, (2012). Non-analgesic effects of opioids: cardiovascular effects of opioids and their receptor systems. Curr Pharm Des 18: 6090-6100.
62. Howells RD, Kilpatrick DL, Bailey LC, Noe M, Udenfriend S, (1986). Proenkephalin mRNA in rat heart. Proc Natl Acad Sci U S A 83: 1960-1963.
63. Hu CP, Peng J, Xiao L, Ye F, Deng HW, Li YJ, (2002). Effect of age on alpha-calcitonin gene-related peptide-mediated delayed cardioprotection induced by intestinal preconditioning in rats. Regul Pept 107: 137-143.
64. Huang MH, Wang HQ, Roeske WR, Birnbaum Y, Wu Y, Yang NP, et al. (2007a). Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell. Am J Physiol Heart Circ Physiol 293: H376-H384.
65. Huang P, Xu W, Yoon SI, Chen C, Chong PL, Liu-Chen LY, (2007b). Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells. Biochem Pharmacol 73: 534-549.
66. Jaiswal A, Kumar S, Seth S, Dinda AK, Maulik SK, (2010). Effect of U50,488H, a κ-opioid receptor agonist on myocardial α- and β-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in rat. Mol Cell Biochem 345: 231-240.
67. Jancso G, Cserepes B, Gasz B, Benko L, Ferencz A, Borsiczky B, et al. (2005). Effect of acetylsalicylic acid on nuclear factor-kappaB activation and on late preconditioning against infarction in the myocardium. J Cardiovasc Pharmacol 46: 295-301.
68. Jang Y, Xi J, Wang H, Mueller RA, Norfleet EA, Xu Z, (2008). Postconditioning prevents reperfusion injury by activating delta-opioid receptors. Anesthesiology 108: 243-250.
69. Jiang X, Shi E, Nakajima Y, Sato S, (2004). Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice. Anesthesiology 101: 82-88.
70. Jordan BA, Trapaidze N, Gomes I, Nivarthi R, Devi LA, (2001). Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci U S A 98: 343-348.
71. Karlsson LO, Bergh N, Li L, Bissessar E, Bobrova I, Gross GJ, et al. (2012). Dose-dependent cardioprotection of enkephalin analogue Eribis peptide 94 and cardiac expression of opioid receptors in a porcine model of ischaemia and reperfusion. Eur J Pharmacol 674: 378-383.
72. Katakam PV, Jordan JE, Snipes JA, Tulbert CD, Miller AW, Busija DW, (2007). Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 292: R920-R926.
73. ATP channel linked mechanisms in rats. Br J Anaesth 84: 204-214.
74. Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC, (2000). Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 278: H1218-H1224.
75. Kevelaitis E, Peynet J, Mouas C, Launay JM, Menasché P, (1999). Opening of potassium channels. The common cardioprotective link between preconditioning and natural hibernation? Circulation 99: 3079-3085.
76. Kim HS, Cho JE, Hwang KC, Shim YH, Lee JH, Kwak YL, (2010). Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival. Eur J Pharmacol 628: 132-139.
77. Kim JH, Chun KJ, Park YH, Kim J, Kim JS, Jang YH, et al. (2011). Morphine-induced postconditioning modulates mitochondrial permeability transition pore opening via δ-1 opioid receptors activation in isolated rat hearts. Korean J Anesthesiol 61: 69-74.
78. Knowles CJ, Cebova M, Pinz IM, (2013). Palmitate diet-induced loss of cardiac caveolin-3: a novel mechanism for lipid-induced contractile dysfunction. PLoS ONE 8: e61369.
79. Kocsis GF, Pipis J, Fekete V, Kovcs-Simon A, Odendaal L, Molnár E, et al. (2008). Lovastatin interferes with infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts. Am J Physiol Heart Circ Physiol 294: H2406-H2409.
80. Kodani E, Xuan YT, Shinmura K, Takano H, Tang XL, Bolli R, (2002). Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. Am J Physiol Heart Circ Physiol 283: H1943-H1957.
81. Koo A, Wong TM, (1983). Cross tolerance between morphine and beta-endorphin in the in vivo vasodilating effect in the hamster cheek pouch. Life Sci 32: 475-477.
82. Lemoine S1, Zhu L, Massetti M, Gérard JL, Hanouz JL, (2011). Continuous administration of remifentanil and sufentanil induces cardioprotection in human myocardium, in vitro. Acta Anaesthesiol Scand 55: 758-764.
83. Lendeckel U, Müller C, Röcken C, Laube B, Täger M, Huth C, et al. (2005). Expression of opioid receptor subtypes and their ligands in fibrillating human atria. Pacing Clin Electrophysiol 28: S275-S279.
84. Lessa MA, Tibiriçá E, (2006). Pharmacologic evidence for the involvement of central and peripheral opioid receptors in the cardioprotective effects of fentanyl. Anesth Analg 103: 815-821.
85. Li L, Zhang H, Li T, Zhang B, (2011). Involvement of adenosine monophosphate-activated protein kinase in morphine-induced cardioprotection. J Surg Res 169: 179-187.
86. Li R, Wong GT, Wong TM, Zhang Y, Xia Z, Irwin MG, (2009). Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats. Anesth Analg 108: 23-29.
87. Lim SY, Yellon DM, Hausenloy DJ, (2010). The neural and humoral pathways in remote limb ischemic preconditioning. Basic Res Cardiol 105: 651-655.
88. Lin J, Wang H, Li J, Wang Q, Zhang S, Feng N, et al. (2013). κ-Opioid receptor stimulation modulates TLR4/NF-κB signaling in the rat heart subjected to ischemia-reperfusion. Cytokine 61: 842-848.
89. Lishmanov AY, Maslov LN, Lasukova TV, Crawford D, Wong TM, (2007). Activation of kappa-opioid receptor as a method for prevention of ischemic and reperfusion arrhythmias: role of protein kinase C and KATP channels. Bull Exp Biol Med 143: 187-190.
90. 2+ homeostasis in rat ventricular myocytes subjected to ischemic insults. J Pharmacol Exp Ther 310: 606-613.
91. Liu L, Mohammadi K, Aynafshar B, Wang H, Li D, Liu J, et al. (2003). Role of caveolae in signal-transducing function of cardiac Na+/K+-ATPase. Am J Physiol Cell Physiol 284: C1550-C1560.
92. Liu M, Zhang P, Chen M, Zhang W, Yu L, Yang XC, et al. (2012). Aging might increase myocardial ischemia/reperfusion-induced apoptosis in humans and rats. Age (Dordr) 34: 621-632.
93. Lu Y, Hu J, Zhang Y, Dong C, (2014). Spinal neuronal NOS activation mediates intrathecal fentanyl preconditioning induced remote cardioprotection in rats. Int Immunopharmacol 19: 127-131.
94. ATP channels and the autonomic nervous system. Life Sci 84: 657-663.
95. Maslov LN, Oeltgen PR, Lishmanov YB, Brown SA, Barzakh EI, Krylatov AV, et al. (2014). Activation of peripheral delta opioid receptors increases cardiac tolerance to arrhythmogenic effect of ischemia/reperfusion. Acad Emerg Med 21: 31-39.
96. Merlocco AC, Redington KL, Disenhouse T, Strantzas SC, Gladstone R, Wei C, et al. (2014). Transcutaneous electrical nerve stimulation as a novel method of remote preconditioning: in vitro validation in an animal model and first human observations. Basic Res Cardiol 109: 406.
97. Michaelis UR, Fisslthaler B, Medhora M, Harder D, Fleming I, Busse R, (2003). Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR). FASEB J 17: 770-772.
98. Michelsen MM, Støttrup NB, Schmidt MR, Løfgren B, Jensen RV, Tropak M, et al. (2012). Exercise-induced cardioprotection is mediated by a bloodborne, transferable factor. Basic Res Cardiol 107: 260.
99. 2+ channel agonists and antagonists in different cardiac tissues. J Auton Pharmacol 12: 437-444.
100. Min TJ, Kim JI, Kim JH, Noh KH, Kim TW, Kim WY, et al. (2011). Morphine postconditioning attenuates ICAM-1 expression on endothelial cells. J Korean Med Sci 26: 290-296.
101. Miura T, Yano T, Naitoh K, Nishihara M, Miki T, Tanno M, et al. (2007). Delta-opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-epsilon-mediated phosphorylation of connexin 43. Am J Physiol Heart Circ Physiol 293: H1425-H1431.
102. Moolman JA, Genade S, Tromp E, Opie LH, Lochner A, (1997). Ischaemic preconditioning does not protect hypertrophied myocardium against ischaemia. S Afr Med J 87: C151-C156.
103. Mougin C, Baulay A, Henriet MT, Haton D, Jacquier MC, Turnill D, et al. (1987). Assessment of plasma opioid peptides, beta-endorphin and met-enkephalin, at the end of an international nordic ski race. Eur J Appl Physiol Occup Physiol 56: 281-286.
104. Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS, (2006). Opioids and cardioprotection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 20: 493-502.
105. Murphy GS, Szokol JW, Marymont JH, Avram MJ, Vender JS, (2007). The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery. Anesth Analg 104: 1334-1342.
106. Nguyen VT, Wu Y, Guillory AN, McConnell BK, Fujise K, Huang MH, (2012). Delta-opioid augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling. Peptides 33: 77-82.
107. Oeltgen PR, Nilekani SP, Nuchols PA, Spurrier WA, Su TP, (1988). Further studies on opioids and hibernation: delta opioid receptor ligand selectively induced hibernation in summer-active ground squirrels. Life Sci 43: 1565-1574.
108. Oh WS, (2002). Effect of fentanyl on TNF-alpha and IL-1beta levels during global ischemia/reperfusion in rats. Int J Tissue React 24: 11-21.
109. Ong EW, Xue L, Olmstead MC, Cahill CM, (2014). Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking. Br J Pharmacol 172: 615-629.
110. Ovize M, Thibault H, Przyklenk K, (2013). Myocardial conditioning: opportunities for clinical translation. Circ Res 113: 439-450.
111. Patel HH, Moore J, Hsu AK, Gross GJ, (2002a). Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism. J Mol Cell Cardiol 34: 1317-1323.
112. ATP channel triggers opioid-induced delayed cardioprotection in the rat. Circ Res 91: 186-188.
113. Patel HH, Fryer RM, Gross ER, Bundey RA, Hsu AK, Isbell M, et al. (2003). 12-lipoxygenase in opioid-induced delayed cardioprotection: gene array, mass spectrometric, and pharmacological analyses. Circ Res 92: 676-682.
114. Patel HH, Head BP, Petersen HN, Niesman IR, Huang D, Gross GJ, et al. (2006). Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors. Am J Physiol Heart Circ Physiol 291: H344-H350.
115. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
116. Peart JN, Gross GJ, (2003). Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors. Am J Physiol Heart Circ Physiol 285: H81-H89.
117. Peart JN, Gross GJ, (2004a). Morphine-tolerant mice exhibit a profound and persistent cardioprotective phenotype. Circulation 109: 1219-1222.
118. Peart JN, Gross GJ, (2004b). Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts. Exp Gerontol 39: 1021-1026.
119. Peart JN, Gross GJ, (2004c). Exogenous activation of delta- and kappa-opioid receptors affords cardioprotection in isolated murine heart. Basic Res Cardiol 99: 29-37.
120. Peart JN, Gross GJ, (2005). Cardioprotection following adenosine kinase inhibition in rat hearts. Basic Res Cardiol 100: 328-336.
121. Peart JN, Gross GJ, (2006). Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways. Am J Physiol Heart Circ Physiol 291: H1746-H1753.
122. Peart JN, Headrick JP, (2009). Clinical cardioprotection and the value of conditioning responses. Am J Physiol Heart Circ Physiol 296: H1705-H1720.
123. Peart JN, Patel HH, Gross GJ, (2003). Delta-opioid receptor activation mimics ischemic preconditioning in the canine heart. J Cardiovasc Pharmacol 42: 78-81.
124. Peart JN, Gross ER, Gross GJ, (2004). Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarction. J Cardiovasc Pharmacol 43: 410-415.
125. Peart JN, Gross ER, Headrick JP, Gross GJ, (2007). Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection. J Mol Cell Cardiol 42: 972-980.
126. Peart JN, Gross ER, Reichelt ME, Hsu A, Headrick JP, Gross GJ, (2008). Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts. Basic Res Cardiol 103: 454-463.
127. Peart JN, Hoe LE, Gross GJ, Headrick JP, (2011). Sustained ligand-activated preconditioning via δ-opioid receptors. J Pharmacol Exp Ther 336: 274-281.
128. Peart JN, Pepe S, Reichelt ME, Beckett N, See Hoe L, Ozberk V, et al. (2014). Dysfunctional survival-signaling and stress-intolerance in aged murine and human myocardium. Exp Gerontol 50: 72-81.
129. Penson PE, Ford WR, Kidd EJ, Broadley KJ, (2008). Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction. Naunyn Schmiedebergs Arch Pharmacol 378: 589-597.
130. Pepe S, Xiao RP, Hohl C, Altschuld R, Lakatta EG, (1997). Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart. Circulation 95: 2122-2129.
131. Pradhan AA, Smith ML, Kieffer BL, Evans CJ, (2012). Ligand-directed signalling within the opioid receptor family. Br J Pharmacol 167: 960-969.
132. Przyklenk K, (2011). Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum. Drugs Aging 28: 331-343.
133. Przyklenk K, (2013). Reduction of myocardial infarct size with ischemic 'conditioning': physiologic and technical considerations. Anesth Anal 117: 891-901.
134. Przyklenk K, Maynard M, Darling CE, Whittaker P, (2008). Aging mouse hearts are refractory to infarct size reduction with post-conditioning. J Am Coll Cardiol 51: 1393-1398.
135. Pugsley MK, (2002). The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. Pharmacol Ther 93: 51-75.
136. Pugsley MK, Saint DA, Penz MP, Walker MJ, (1993). Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289. Br J Pharmacol 110: 1579-1585.
137. Pugsley MK, Saint DA, Hayes ES, Kramer D, Walker MJ, (1998). Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat. J Cardiovasc Pharmacol 32: 863-874.
138. Qi JS, Kam KW, Chen M, Wu S, Wong TM, (2004). Failure to confer cardioprotection and to increase the expression of heat-shock protein 70 by preconditioning with a kappa-opioid receptor agonist during ischaemia and reperfusion in streptozotocin-induced diabetic rats. Diabetologia 47: 214-220.
139. Rehni AK, Singh N, Jaggi AS, (2007). Possible involvement of insulin, endogenous opioids and calcitonin gene-related peptide in remote ischaemic preconditioning of the brain. Yakugaku Zasshi 127: 1013-1020.
140. Rentoukas I, Giannopoulos G, Kaoukis A, Kossyvakis C, Raisakis K, Driva M, et al. (2010). Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. JACC Cardiovasc Interv 3: 49-55.
141. Riess ML, Camara AK, Rhodes SS, McCormick J, Jiang MT, Stowe DF, (2005). Increasing heart size and age attenuate anesthetic preconditioning in guinea pig isolated hearts. Anesth Analg 101: 1572-1576.
142. Romano MA, McNish R, Seymour EM, Traynor JR, Bolling SF, (2004a). Differential effects of opioid peptides on myocardial ischemic tolerance. J Surg Res 119: 46-50.
143. Romano MA, Seymour EM, Berry JA, McNish RA, Bolling SF, (2004b). Relative contribution of endogenous opioids to myocardial ischemic tolerance. J Surg Res 118: 32-37.
144. Roth-Isigkeit A, Dibbelt L, Schmucker P, Seyfarth M, (2000). The immune-endocrine interaction varies with the duration of the inflammatory process in cardiac surgery patients. J Neuroendocrinol 12: 546-552.
145. Ruiz-Meana M, Núñez E, Miro-Casas E, Martínez-Acedo P, Barba I, Rodriguez-Sinovas A, et al. (2014). Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol. J Mol Cell Cardiol 68: 79-88.
146. Schulman D, Latchman DS, Yellon DM, (2001). Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 281: H1630-H1636.
147. Schultz J, Hsu AK, Nagase H, Gross GJ, (1998b). TAN-67, a delta 1-opioid receptor agonist, reduces infarct size via activation of Gi/o proteins and KATP channels. Am J Physiol 274: H909-H914.
148. Schultz JE, Gross GJ, (2001). Opioids and cardioprotection. Pharmacol Ther 89: 123-137.
149. Schultz JE, Rose E, Yao Z, Gross GJ, (1995). Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 268: H2157-H2161.
150. Schultz JE, Hsu AK, Gross GJ, (1996). Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78: 1100-1104.
151. Schultz JE, Hsu AK, Gross GJ, (1998a). Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation 97: 1282-1289.
152. Schultz JJ, Hsu AK, Gross GJ, (1997). Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol 29: 1355-1362.
153. See Hoe L, Zemljic-Harpf A, Schilling J, Finley C, Kellerhals S, Roth R, et al. (2013). Opioid-mediated sustained ligand-activated preconditioning induces cardiac protection in type II diabetes mellitus. FASEB J 27: 1169.5.
154. See Hoe L, Headrick JP, Peart JN, (2014a). Chronic β1-blockade impairs ischemic tolerance and preconditioning in murine myocardium (652.2). FASEB J 28: 652-2.
155. See Hoe LE, Schilling JM, Tarbit E, Kiessling CJ, Busija AR, Niesman IR, et al. (2014b). Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance and opioidergic cardioprotection. Am J Physiol Heart Circ Physiol 307: H895-H903.
156. Seymour EM, Wu SY, Kovach MA, Romano MA, Traynor JR, Claycomb WC, et al. (2003). HL-1 myocytes exhibit PKC and K(ATP) channel-dependent delta opioid preconditioning. J Surg Res 114: 187-194.
157. Sharma NK, Mahadevan N, Balakumar P, (2013). Adenosine transport blockade restores attenuated cardioprotective effects of adenosine preconditioning in the isolated diabetic rat heart: potential crosstalk with opioid receptors. Cardiovasc Toxicol 13: 22-32.
158. Shen H, Ben Q, Zhang Y, Jiang G, Yao C, Shi D, et al. (2012). Role of δ2 opioid receptor in cardioprotection against hypoxia-reoxygenation injury. J Cardiovasc Pharmacol 60: 253-261.
159. 2+ in rat ventricular myocytes. Life Sci 59: 2181-2186.
160. Shi W, Vinten-Johansen J, (2012). Endogenous cardioprotection by ischaemic postconditioning and remote conditioning. Cardiovasc Res 94: 206-216.
161. Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, et al. (2009). Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond) 117: 191-200.
162. Shinmura K, Kodani E, Xuan YT, Dawn B, Tang XL, Bolli R, (2003). Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits. JACC 41: 1183-1194.
163. Sigg D, Coles JA Jr, Oeltgen PR, Iaizzo PA, (2002). Role of delta-opioid receptor agonists on infarct size reduction in swine. Am J Physiol Heart Circ Physiol 282: H1953-H1960.
164. Skrabalova J, Neckar J, Hejnova L, Bartonova I, Kolar F, Novotny J, (2012). Antiarrhythmic effect of prolonged morphine exposure is accompanied by altered myocardial adenylyl cyclase signaling in rats. Pharmacol Rep 64: 351-359.
165. Sobanski P, Krajnik M, Shaqura M, Bloch-Boguslawska E, Schäfer M, Mousa SA, (2014). The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue. Heart Vessels 29: 855-863.
166. Suematsu Y, Anttila V, Takamoto S, del Nido P, (2004). Cardioprotection afforded by ischemic preconditioning interferes with chronic beta-blocker treatment. Scand Cardiovasc J 38: 293-299.
167. 1 receptors mediates cardioprotection by remote ischemic preconditioning. J Mol Cell Cardiol 60: 142-150.
168. Tadevosyan A, Vaniotis G, Allen BG, Hébert TE, Nattel S, (2012). G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function. J Physiol 590: 1313-1330.
169. ATP channels mimics preconditioning but PKC activation is less effective in middle-aged rat hearts. Cardiovasc Res 49: 56-68.
170. Terashvili M, Tseng LF, Wu HE, Narayanan J, Hart LM, Falck JR, et al. (2008). Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray. J Pharmacol Exp Ther 326: 614-622.
171. Theisen MM, Schlottmann S, August C, Herzog C, Theilmeier G, Maas M, et al. (2014). Detection and distribution of opioid peptide receptors in porcine myocardial tissue. Pharmacol Res 84: 45-49.
172. Tomai F, Crea F, Gaspardone A, Versaci F, Ghini AS, De Paulis R, et al. (1997). Phentolamine prevents adaptation to ischemia during coronary angioplasty: role of α-adrenergic receptors in ischemic preconditioning. Circulation 96: 2171-2177.
173. Tomai F, Crea F, Gaspardone A, Versaci F, Ghini AS, Ferri C, et al. (1999). Effects of naloxone on myocardial ischemic preconditioning in humans. J Am Coll Cardiol 33: 1863-1869.
174. Tong G, Sun Z, Wei X, Gu C, Kaye AD, Wang Y, et al. (2011). U50,488H postconditioning reduces apoptosis after myocardial ischemia and reperfusion. Life Sci 88: 31-38.
175. Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, Patel HH, (2007). Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci 81: 1223-1227.
176. Tsutsumi YM, Kawaraguchi Y, Niesman IR, Patel HH, Roth DM, (2010). Opioid-induced preconditioning is dependent on caveolin-3 expression. Anesth Analg 111: 1117-1121.
177. Valtchanova-Matchouganska A, Ojewole JA, (2003). Mechanisms of opioid delta and kappa receptors' cardioprotection in ischaemic preconditioning in a rat model of myocardial infarction. Cardiovasc J S Afr 14: 73-80.
178. Ventura C, Bastagli L, Bernardi P, Caldarera CM, Guarnieri C, (1989). Opioid receptors in rat cardiac sarcolemma: effect of phenylephrine and isoproterenol. Biochim Biophys Acta 987: 69-74.
179. 2+ release from an intracellular pool in myocytes and neurons. Circ Res 70: 66-81.
180. Ventura C, Maioli M, Pintus G, Posadino AM, Tadolini B, (1998). Nuclear opioid receptors activate opioid peptide gene transcription in isolated myocardial nuclei. J Biol Chem 273: 13383-13386.
181. Villemagne PS, Dannals RF, Ravert HT, Frost JJ, (2002). PET imaging of human cardiac opioid receptors. Eur J Nucl Med Mol Imaging 29: 1385-1388.
182. Wagner C, Kloeting I, Strasser RH, Weinbrenner C, (2008). Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3β. J Cardiovasc Pharmacol 52: 430-437.
183. Wang GY, Wu S, Pei JM, Yu XC, Wong TM, (2001). Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am J Physiol Heart Circ Physiol 280: H384-H391.
184. Wang J, Gao Q, Sun GQ, Zhou HO, Xia Q, (2008). Delta-opioid receptor mediates the cardioprotective effect of ischemic postconditioning. Zhongguo Ying Yong Sheng Li Xue Za Zhi 24: 184-189.
185. Wang S, Duan Y, Su D, Li W, Tan J, Yang D, et al. (2011). Delta opioid peptide [D-Ala2, D-Leu5] enkephalin (DADLE) triggers postconditioning against transient forebrain ischemia. Eur J Pharmacol 658: 140-144.
186. Wang TL, Chang H, Hung CR, Tseng ZY, (1998). Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction. Cardiovasc Res 40: 557-563.
187. Wanke T, Auinger M, Formanek D, Merkle M, Lahrmann H, Ogris E, et al. (1996). Defective endogenous opioid response to exercise in type I diabetic patients. Metabolism 45: 137-142.
188. Weil J, Zolk O, Griepentrog J, Wenzel U, Zimmermann WH, Eschenhagen T, (2006). Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction. Cardiovasc Res 69: 412-422.
189. Weinbrenner C, Schulze F, Sárváry L, Strasser RH, (2004). Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. Cardiovasc Res 61: 591-599.
190. Wever KE, Masereeuw R, Wagener FA, Verweij VG, Peters JG, Pertijs JC, et al. (2013). Humoral signalling compounds in remote ischaemic preconditioning of the kidney, a role for the opioid receptor. Nephrol Dial Transplant 28: 1721-1732.
191. 1 adenosine receptors and ischemic preconditioning. Am J Physiol Heart Circ Physiol 300: H2161-H2168.
192. Williams-Pritchard GA, Peart JN, Headrick JP, (2008). Transcriptional and cell signaling cross-talk between adenosine and opioid receptors in cardiac cells. Circulation 118: S293.
193. Wittert G, Hope P, Pyle D, (1996). Tissue distribution of opioid gene expression in the rat. Biochem Biophys Res Commun 218: 877-888.
194. Wong GT, Huang Z, Ji S, Irwin MG, (2010a). Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. J Cardiothorac Vasc Anesth 24: 790-796.
195. Wong GT, Li R, Jiang LL, Irwin MG, (2010b). Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation. Acta Anaesthesiol Scand 54: 510-518.
196. Wong GT, Lu Y, Mei B, Xia Z, Irwin MG, (2012a). Cardioprotection from remote preconditioning involves spinal opioid receptor activation. Life Sci 91: 860-865.
197. Wong GT, Yao L, Xia Z, Irwin MG, (2012b). Intrathecal morphine remotely preconditions the heart via a neural pathway. J Cardiovasc Pharmacol 60: 172-178.
198. Wong TM, Lee AY, (1987). Chronic morphine treatment reduces the incidence of ventricular arrhythmias in the isolated rat heart induced by dynorphin1-13 or myocardial ischemia and reperfusion. Neurosci Lett 77: 61-65.
199. 2+ transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes-role of CaMKIIdelta(B). Eur J Pharmacol 595: 52-57.
200. Wu QL, Shen T, Ma H, Wang JK, (2012a). Sufentanil postconditioning protects the myocardium from ischemia-reperfusion via PI3K/Akt-GSK-3β pathway. J Surg Res 178: 563-570.
201. Wu S, Li HY, Wong TM, (1999). Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res 84: 1388-1395.
202. Wu Y, Gu EW, Zhu Y, Zhang L, Liu XQ, Fang WP, (2012b). Sufentanil limits the myocardial infarct size by preservation of the phosphorylated connexin 43. Int Immunopharmacol 13: 341-346.
203. Xu ZD, Jin M, He WX, Xia SX, Zhao YF, He B, et al. (2009). Remifentanil preconditioning lowers cardiac troponin 1 level in patients undergoing off-pump coronary artery bypass graft surgery. Nan Fang Yi Ke Da Xue Xue Bao 29: 1554-1556.
204. Yao L, Wong GT, Xia Z, Irwin MG, (2011). Interaction between spinal opioid and adenosine receptors in remote cardiac preconditioning: effect of intrathecal morphine. J Cardiothorac Vasc Anesth 25: 444-448.
205. Yin W, Zhang P, Huang JH, Zhang QY, Fan R, Li J, et al. (2009). Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis. Eur J Pharmacol 607: 135-142.
206. Zatta AJ, Kin H, Yoshishige D, Jiang R, Wang N, Reeves JG, et al. (2008). Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol Heart Circ Physiol 294: H1444-H1451.
207. Zhang QY, Wang W, Shi QX, Li YL, Huang JH, Yao Y, et al. (2010). Antiarrhythmic effect mediated by κ-opioid receptor is associated with Cx43 stabilization. Crit Care Med 38: 2365-2376.
208. Zhang R, Shen L, Xie Y, Gen L, Li X, Ji Q, (2013). Effect of morphine-induced postconditioning in corrections of tetralogy of fallot. J Cardiothorac Surg 8: 76.
209. Zhang SZ, Wang NF, Xu J, Gao Q, Lin GH, Bruce IC, et al. (2006). Kappa-opioid receptors mediate cardioprotection by remote preconditioning. Anesthesiology 105: 550-556.
210. Zhang Y, Irwin MG, Wong TM, (2004). Remifentanil preconditioning protects against ischemic injury in the intact rat heart. Anesthesiology 101: 918-923.
211. Zhang Y, Irwin MG, Lu Y, Mei B, Zuo YM, Chen ZW, et al. (2011). Intracerebroventricular administration of morphine confers remote cardioprotection-role of opioid receptors and calmodulin. Eur J Pharmacol 656: 74-80.
212. Zhou Y, Fathali N, Lekic T, Ostrowski RP, Chen C, Martin RD, et al. (2011). Remote limb ischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in rat pups by the opioid receptor/Akt pathway. Stroke 42: 439-444.
213. Zimlichman R, Gefel D, Eliahou H, Matas Z, Rosen B, Gass S, et al. (1996). Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation 93: 1020-1025.